Upregulation of Extrasynaptic Inhibitory Receptors Protects against Anorexa nervosa

by | Feb 20, 2017

Results suggest that treatments targeting the activation of specific receptors may be efficacious in preventing the development or relapse of anorexia nervosa.

Anorexia nervosa is a debilitating disease characterized by continuously severe, self-imposed starvation and intense comorbid anxiety, which manifests as a fear of gaining weight. Anorexia has a lifetime prevalence of 1-2% worldwide, affects females nine times more than males, and has the highest mortality rate of any mental illness, surpassing depression. Despite the severity of this disease, no accepted pharmacological treatments exist and current treatments, such as benzodiazepines, are not efficacious in treating the disease or preventing relapse.

Recent studies suggest that the expression of α4βδ-GABAA receptors contribute to the regulation of mental disorders, including anxiety, depression, premenstrual dysphoric disorder, and anorexia nervosa. In particular, previous work has shown that in animal models of anorexia nervosa, the expression of α4βδ-GABAA receptors at extrasynaptic locations in the hippocampus increases.

Hypothesized sequence of events leading to the upregulation of α4βδ-GABAARs at synaptic clefts of ABA tissue. More information here.

In a new study published online, Aoki and colleagues set out to examine whether food restriction alone, exercise alone, or both combined, contribute to changes in the expression of α4βδ-GABAA receptors in CA1 pyramidal neurons. They found that exercise alone during adolescence increased the localization of α4βδ-GABAA receptors to spine synapses and that increased expression of α4βδ-GABAA receptors contributes to suppression of food restriction-evoked hyperactivity, protecting animals from excessive weight loss. These results imply that the upregulation of α4βδ-GABAA receptors may increase resilience after a stressful experience, while a failure to upregulate α4βδ-GABAA receptors at excitatory synapses may increase the risk for developing symptoms associated with anorexia nervosa. These results further suggest that treatments targeting the activation of α4βδ-GABAA receptors may be efficacious in preventing the development or relapse of anorexia nervosa.

ASN Weekly

Sign up for our weekly newsletter and receive the latest science news.

Related posts: